{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T14:33:44Z","timestamp":1721572424396},"reference-count":54,"publisher":"Wiley","issue":"S3","license":[{"start":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T00:00:00Z","timestamp":1601164800000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aripiprazole, a dopamine partial agonist, is a second\u2010generation anti\u2010psychotic that is widely used for the treatment of schizophrenia and other psychotic disorders. A group of psychiatric experts in Hong Kong developed a set of consensus statements, aiming to facilitate the understanding of clinical properties and usages of aripiprazole among local physicians. Of note, because aripiprazole long\u2010acting injectable has been available locally not long before the establishment of the consensus panel, which limited the discussion on its use in the local context, the consensus statements were focused primarily on oral aripiprazole. To draft the consensus statements, the panellists discussed the published evidence and their clinical experience regarding aripiprazole in a series of meetings based on several areas. At the final meeting, each drafted statement was voted on anonymously by all panellists based on its practicability of recommendation in Hong Kong. A set of consensus statements on the characteristics and clinical use of aripiprazole was established and accepted by the panel. These statements serve to provide a practical reference for physicians in Hong Kong, and possibly other parts of the Asia\u2010Pacific region, on the use of aripiprazole in people with schizophrenia spectrum disorders and other psychotic problems.<\/jats:p>","DOI":"10.1111\/imj.14896","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T02:35:25Z","timestamp":1601260525000},"page":"6-14","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong"],"prefix":"10.1111","volume":"50","author":[{"given":"Michael M. C.","family":"Wong","sequence":"first","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert K. K.","family":"Chung","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M. H.","family":"Yeung","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T. W.","family":"Wong","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. K.","family":"Lee","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Lai","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria F. Y.","family":"Chan","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory K. L.","family":"Mak","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica O. Y.","family":"Wong","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger M. K.","family":"Ng","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. L.","family":"Tam","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Y.","family":"Mak","sequence":"additional","affiliation":[{"name":"Asian Association of Neuropsychopharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,9,27]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418040-00005"},{"key":"e_1_2_6_3_1","first-page":"638","article-title":"Schizophrenia: overview and treatment options","volume":"39","author":"Patel KR","year":"2014","journal-title":"P T"},{"key":"e_1_2_6_4_1","volume-title":"The Delphi Method: Techniques and Applications","author":"Linstone HA","year":"2002"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06241.x"},{"key":"e_1_2_6_6_1","first-page":"2635","article-title":"Aripiprazole: from pharmacological profile to clinical use","volume":"11","author":"Di Sciascio G","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.01.021"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.schres.2014.05.040","article-title":"Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double\u2010blind, active parallel\u2010controlled, multicenter clinical trial","volume":"157","author":"Li H","year":"2014","journal-title":"Schizophr Res"},{"key":"e_1_2_6_9_1","first-page":"CD005000","article-title":"Aripiprazole alone or in combination for acute mania","volume":"12","author":"Brown R","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3782"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/11538980-000000000-00000"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.12088"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.22485"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.08.053"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.5262"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-014-0078-0"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7150\/ijms.10453","article-title":"Antipsychotics\u2010associated serious adverse events in children: an analysis of the FAERS database","volume":"12","author":"Kimura G","year":"2015","journal-title":"Int J Med Sci"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110376685"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0278-3"},{"key":"e_1_2_6_20_1","first-page":"421","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review","volume":"28","author":"Peuskens J","year":"2014","journal-title":"CNS Drugs"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.12.033"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000175"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139717"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2015.01.004"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-012-0003-4"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2013.11.2.60"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5416-06.2007"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbr006"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000426"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00498.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X210633"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1013029"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.951325"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3749"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000171"},{"key":"e_1_2_6_36_1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1017\/S1092852900002273","article-title":"Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies","volume":"9","author":"Madhusoodanan S","year":"2004","journal-title":"CNS Spectr"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000348369.19172.ba"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0106"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00308-6"},{"key":"e_1_2_6_40_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/CIA.S9398","article-title":"Aripiprazole for late\u2010life schizophrenia","volume":"5","author":"Rado J","year":"2010","journal-title":"Clin Interv Aging"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e3181b76658"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-012-0270-0"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m08189"},{"key":"e_1_2_6_44_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12888-015-0504-z","article-title":"Aripiprazole for the treatment of tic disorders in children: a systematic review and meta\u2010analysis","volume":"15","author":"Yang CS","year":"2015","journal-title":"BMC Psychiatry"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205700302"},{"key":"e_1_2_6_46_1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pnpbp.2007.10.009","article-title":"Effectiveness of aripiprazole in treating obsessive compulsive symptoms","volume":"32","author":"Yang KC","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.3109\/13651501.2011.605958"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181fab7b1"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1202"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0124"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1123145"},{"key":"e_1_2_6_52_1","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2147\/NDT.S91397","article-title":"Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta\u2010analysis of randomized controlled trials","volume":"11","author":"Oya K","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.134213"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.12.013"},{"key":"e_1_2_6_55_1","unstructured":"Drug Office Department of Health. 2018 [cited 25 Mar 2019]. Registered Pharmaceutical Products. Available from URL:http:\/\/www.drugoffice.gov.hk\/eps\/do\/en\/level.html"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.14896","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.14896","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.14896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T09:20:43Z","timestamp":1693905643000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.14896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":54,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1111\/imj.14896"],"URL":"https:\/\/doi.org\/10.1111\/imj.14896","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"2020-09-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}